• Home
  • Search
  • Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme
  • Cite Icon268
  • https://doi.org/10.2471/blt.11.097253Copy DOI Icon

Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme

Show More
  • Abstract
  • Highlights & Summary
  • PDF
  • Literature Map
  • References
  • Citations
  • Similar Papers
Abstract

Virtually all women who have cervical cancer are infected with the human papillomavirus (HPV). Of the 275,000 women who die from cervical cancer every year, 88% live in developing countries. Two vaccines against the HPV have been approved. However, vaccine implementation in low-income countries tends to lag behind implementation in high-income countries by 15 to 20 years. In 2011, Rwanda's Ministry of Health partnered with Merck to offer the Gardasil HPV vaccine to all girls of appropriate age. The Ministry formed a "public-private community partnership" to ensure effective and equitable delivery. Thanks to a strong national focus on health systems strengthening, more than 90% of all Rwandan infants aged 12-23 months receive all basic immunizations recommended by the World Health Organization. In 2011, Rwanda's HPV vaccination programme achieved 93.23% coverage after the first three-dose course of vaccination among girls in grade six. This was made possible through school-based vaccination and community involvement in identifying girls absent from or not enrolled in school. A nationwide sensitization campaign preceded delivery of the first dose. Through a series of innovative partnerships, Rwanda reduced the historical two-decade gap in vaccine introduction between high- and low-income countries to just five years. High coverage rates were achieved due to a delivery strategy that built on Rwanda's strong vaccination system and human resources framework. Following the GAVI Alliance's decision to begin financing HPV vaccination, Rwanda's example should motivate other countries to explore universal HPV vaccine coverage, although implementation must be tailored to the local context.

Loading PDF

Similar Papers
  • PDF
  • Abstract
  • Citations3

HPV vaccines in Brazil and the world

  • Oct 01, 2014
  • BMC Proceedings
  • Luisa Villa
  • Research Article
  • Citations3

Health Care Provider Perceptions of Facilitators and Barriers to Human Papillomavirus Vaccination Delivery in Five Countries.

  • May 11, 2021
  • Sexually transmitted diseases
  • Jessica Y Islam +8
  • Research Article

Immune Response 2019 : Factors influencing intention to obtain the HPV vaccine among a population of universitywomen in morocco - Dr. Aicha yacouti â University of Hassan

  • Jan 01, 2019
  • Aicha Yacouti
  • Research Article
  • Citations73

Knowledge of cervix cancer, human papilloma virus (HPV) and HPV vaccination at the moment of introduction of the vaccine in women in Belgium

  • Oct 27, 2007
  • Archives of Gynecology and Obstetrics
  • Gilbert G G Donders +6
  • Research Article
  • Citations19

Knowledge, Attitude, and Practice of Cervical Cancer Screening, and HPV Vaccination: A Cross-Sectional Study Among Obstetricians and Gynecologists in Egypt.

  • Jan 21, 2022
  • Maternal and Child Health Journal
  • Mariam Lotfy Mohamed +3
  • Book Chapter
  • Citations1

Prevention of Cervical Cancer: Era of HPV Testing and Vaccination

  • Jan 01, 2017
  • Kazuhiko Ino
  • Research Article

Author's Response: HPV vaccination in India

  • Sep 01, 2012
  • Journal of the Royal Society of Medicine
  • A M Pollock +2
  • PDF
  • Research Article
  • Citations58

Knowledge, attitudes, practices and willingness to vaccinate in preparation for the introduction of HPV vaccines in Bamako, Mali

  • Feb 13, 2017
  • PLOS ONE
  • Anne S De Groot +8
  • Research Article
  • Citations109

Parental acceptance of human papillomavirus (HPV) vaccination in Indonesia: A cross-sectional study

  • Aug 05, 2011
  • Vaccine
  • L Jaspers +4
  • Research Article

Abstract 1032: Knowledge, attitude and practices regarding human papillomavirus (HPV) and HPV vaccination among medical undergraduate students in Delhi: A cross-sectional study

  • Apr 21, 2025
  • Cancer Research
  • Srishty Srishty +4
  • Research Article
  • Citations35

Human papillomavirus vaccination acceptance and hesitancy in South Africa: Research and policy agenda.

  • Dec 13, 2018
  • South African Medical Journal
  • N J Ngcobo +3
  • Research Article
  • Citations1

Questionnaires survey on the cognition of prevention and treatment for cervical lesions among females from Shenzhen communities

  • Sep 06, 2016
  • Chinese Journal of Modern Nursing
  • You Zhou +1
  • Research Article

Abstract D014: Assessing an intervention to increase cervical cancer knowledge and HPV vaccination knowledge among predominantly African American communities in South Carolina

  • Jun 01, 2020
  • Cancer Epidemiology, Biomarkers & Prevention
  • Marvella E Ford +6
  • PDF
  • Research Article
  • Citations10

Efficacy of prophylactic human papillomavirus vaccines on cervical cancer among the Asian population: A meta-analysis.

  • Dec 02, 2022
  • Frontiers in Microbiology
  • Xinyu Ren +6
  • Research Article
  • Citations17

A study on the predictors of Korean male students' intention to receive human papillomavirus vaccination.

  • Aug 17, 2016
  • Journal of Clinical Nursing
  • Jeong Sil Choi +1
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.